| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 4.793 | 19.595 | 115.453 | 0 | 468 |
| Total Income - EUR | - | - | - | - | - | 4.793 | 19.595 | 115.453 | 589 | 4.709 |
| Total Expenses - EUR | - | - | - | - | - | 2.073 | 4.758 | 1.234 | 14.544 | 11.126 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 2.720 | 14.837 | 114.218 | -13.955 | -6.417 |
| Net Profit/Loss - EUR | - | - | - | - | - | 2.583 | 14.247 | 113.371 | -13.955 | -6.417 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Docarpat S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 620 | 455 | 304 | 7.534 | 5.693 |
| Current Assets | - | - | - | - | - | 18.041 | 14.463 | 115.149 | 2.255 | 113 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 15.871 | 14.463 | 114.723 | 112 | 0 |
| Cash | - | - | - | - | - | 2.170 | 0 | 426 | 2.143 | 113 |
| Shareholders Funds | - | - | - | - | - | 2.624 | 14.296 | 113.420 | 3.700 | -2.738 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 16.059 | 655 | 2.042 | 6.145 | 8.603 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7021 - 7021" | |||||||||
| CAEN Financial Year |
7021
|
|||||||||
Comments - Docarpat S.r.l.